Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cervera

Showing results (171-180 of 328) with videos related to

Pageof 33
Sort By:
Annals of the Rheumatic Diseases|July 29, 2020
COVID-19 and Behçet's disease: clinical case seriesGerard Espinosa, Olga Araujo, Sergi Amaro, et al.
British Journal of Rheumatology|January 1, 1997
Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndromeM Teixidó, J Font, J C Reverter, et al.
Lupus|June 2, 1998
Young onset of primary Sjögren's syndrome: clinical and immunological characteristicsM Ramos-Casals, R Cervera, J Font, et al.
Lupus|January 1, 1997
Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapyF J Muñoz-Rodríguez, J Font, J R Badia, et al.
Clinical and Experimental Rheumatology|February 18, 2012
Mortality and long term survival prognostic factors of patients with systemic autoimmune diseases admitted to an intensive care unit: a retrospective studyJ M Antón, P Castro, G Espinosa, et al.
Annals of the New York Academy of Sciences|September 26, 2007
Cross-reactive epitopes on beta2-glycoprotein-I and Saccharomyces cerevisiae in patients with the antiphospholipid syndromeI Krause, M Blank, R Cervera, et al.
Autoimmunity Reviews|December 2, 2006
The catastrophic antiphospholipid (Asherson's) syndrome and malignanciesW Miesbach, R A Asherson, R Cervera, et al.
Postgraduate Medical Journal|November 1, 1991
Polymyositis complicating D-penicillamine treatmentA O Aydintug, R Cervera, D D'Cruz, et al.
Medicina Clinica|May 3, 1997
[Primary Sjögren's syndrome: clinical and immunologic study of 80 patients]M Ramos, R Cervera, M García-Carrasco, et al.
Lupus|February 1, 1995
Lack of relationship between human immunodeficiency virus infection and systemic lupus erythematosusJ Font, J Vidal, R Cervera, et al.
Pageof 33

Showing results (171-180 of 328) with videos related to

Sort By:
Pageof 33
Annals of the Rheumatic Diseases|July 29, 2020
COVID-19 and Behçet's disease: clinical case seriesGerard Espinosa, Olga Araujo, Sergi Amaro, et al.
British Journal of Rheumatology|January 1, 1997
Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndromeM Teixidó, J Font, J C Reverter, et al.
Lupus|June 2, 1998
Young onset of primary Sjögren's syndrome: clinical and immunological characteristicsM Ramos-Casals, R Cervera, J Font, et al.
Lupus|January 1, 1997
Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapyF J Muñoz-Rodríguez, J Font, J R Badia, et al.
Clinical and Experimental Rheumatology|February 18, 2012
Mortality and long term survival prognostic factors of patients with systemic autoimmune diseases admitted to an intensive care unit: a retrospective studyJ M Antón, P Castro, G Espinosa, et al.
Annals of the New York Academy of Sciences|September 26, 2007
Cross-reactive epitopes on beta2-glycoprotein-I and Saccharomyces cerevisiae in patients with the antiphospholipid syndromeI Krause, M Blank, R Cervera, et al.
Autoimmunity Reviews|December 2, 2006
The catastrophic antiphospholipid (Asherson's) syndrome and malignanciesW Miesbach, R A Asherson, R Cervera, et al.
Postgraduate Medical Journal|November 1, 1991
Polymyositis complicating D-penicillamine treatmentA O Aydintug, R Cervera, D D'Cruz, et al.
Medicina Clinica|May 3, 1997
[Primary Sjögren's syndrome: clinical and immunologic study of 80 patients]M Ramos, R Cervera, M García-Carrasco, et al.
Lupus|February 1, 1995
Lack of relationship between human immunodeficiency virus infection and systemic lupus erythematosusJ Font, J Vidal, R Cervera, et al.
Pageof 33